The Most Influential COVID-19 Articles: A Systematic Review

preprint OA: closed
View at publisher
AI-generated summary by claude@2026-07, 2026-07-15

This systematic review identified the 100 most cited COVID-19 articles, finding they primarily focused on diagnosis, transmission, and therapy and originated mainly from China and the USA, despite having a low average level of evidence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as causative pathogen of coronavirus disease 2019 (COVID-19), has posed a Pandemic to global health with challenges for the health care system all around the world. Researchers studied and published on the SARS-CoV-2 and the disease intensively. What is the significance of articles published, shared and cited in the early stages of such a pandemic? Materials and methods: A systematic literature search in a time frame of 12 months and analyse rating using Principle Component Analysis (PCA) and Multiple Factor Analysis (MFA) were performed.Results: Hundred most cited COVID-19 articles were identified; 54 of than were from China, followed by United States of America (USA) (n = 21); United Kingdom (UK) (n = 8). All articles were published in high-ranked, peer-reviewed journals. Main focus of the articles were diagnosis, transmission and therapy of COVID-19. The level of evidence of the 100 most cited COVID-19 articles in average was low.Conclusion: In the early stages of a pandemic, new and pioneering research results can be shown to emerge and be highly cited, regardless of the level of evidence.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00